Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedNew guidance and help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), along with a note that recruitment is no longer open to participants. The Interventions section label has been updated, and the site revision has advanced to v3.6.0, replacing v3.5.5.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer version of the page/document. This change is a metadata update rather than a substantive modification to the study details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, reflecting a new version of the page. This update appears to be a minor administrative/versioning change and does not modify the study details or visible content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov page version rather than study details.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision update: from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.